Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC1 | P33527 | 3/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | SHMT2 | P34897 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1876681 | 0.81 | TSHR (0.42) | TSHRTP53ALDH1A1KMT2A | |
| SCHEMBL5472836 | 0.78 | TSHR (0.33) | TSHRKMT2A | |
| SCHEMBL5481191 | 0.78 | MTOR (0.32) | TP53KMT2A | |
| SCHEMBL6554139 | 0.78 | ALDH1A1 (0.53) | RAB9ALMNATSHRNPC1GAA | |
| SCHEMBL1133942 | 0.77 | MAPT (0.47) | POLBRAB9ANPC1SMN1; SMN2GAA | |
| SCHEMBL3761623 | 0.77 | LMNA (0.36) | POLBLMNASMN1; SMN2ALDH1A1MEN1 | |
| SCHEMBL6294612 | 0.77 | MAPT (0.43) | ALDH1A1USP2 | |
| SCHEMBL27562668 | 0.76 | CASR (0.36) | CA12CA1CA2CA9POLB | |
| SCHEMBL2181642 | 0.75 | TERT (0.49) | POLBTSHRSMN1; SMN2GAAALDH1A1 | |
| SCHEMBL3126679 | 0.75 | LMNA (0.38) | CA12CA1CA2CA9HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10344032-B2 | Agents for treating neurogenic inflammation and neuropathic hyperalgesia related disorders | PÉCSI TUDOMÁNYEGYETEM (HU) | 2019-07-09 | — | — | US | claimed |
| EP-3194399-B1 | NEW AGENTS FOR TREATING NEUROGENIC INFLAMMATION AND NEUROPATHIC HYPERALGESIA RELATED DISORDERS | PECSI TUDOMANYEGYETEM (HU) | 2019-04-10 | — | — | EP | claimed |
| EP-3194399-B1 | NEW AGENTS FOR TREATING NEUROGENIC INFLAMMATION AND NEUROPATHIC HYPERALGESIA RELATED DISORDERS | PECSI TUDOMANYEGYETEM (HU) | 2019-04-10 | — | — | EP | disclosed |
| US-8350995-B2 | Optical film, production method of optical film, optically-compensatory film, polarizing plate and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2013-01-08 | — | — | US | disclosed |
| US-8147638-B2 | Polarizing plate and display using the same | KONICA MINOLTA OPTO INC. (JP) | 2012-04-03 | — | — | US | disclosed |
| US-20110155306-A1 | POLARIZING PLATE AND DISPLAY USING THE SAME | KONICA MINOLTA OPTO, INC. (JP) | 2011-06-30 | — | — | US | disclosed |
| US-7968019-B2 | Optical compensation film, method for producing optical compensation film, polarization plate and liquid crystal display | KONICA MINOLTA OPTO, INC. (JP) | 2011-06-28 | — | — | US | disclosed |
| US-7922947-B2 | Method of producing dispersion | FUJIFILM CORPORATION (JP) | 2011-04-12 | — | — | US | disclosed |
| US-7635506-B2 | Stretched cellulose ester film, hard coat film, antireflective film, and optical compensation film, and polarizing plate, and display device using them | KONICA MINOLTA OPTO, INC. (JP) | 2009-12-22 | — | — | US | disclosed |
| US-20090192256-A1 | POLYMER BLEND FILM CONTAINING CYCLIC POLYOLEFIN | FUJIFILM CORPORATION (JP) | 2009-07-30 | — | — | US | disclosed |
| US-7541074-B2 | Optical film and optical compensatory film, polarizing plate and liquid crystal display using same | FUJIFILM CORPORATION (JP) | 2009-06-02 | — | — | US | disclosed |
| US-7153552-B2 | Polarizing plate and display | KONICA MINOLTA OPTO, INC. (JP) | 2006-12-26 | — | — | US | disclosed |
| US-20060216437-A1 | Optical compensation film, method for producing optical compensation film, polarization plate and liquid crystal display | KONICA MINOLTA OPTO, INC. (JP) | 2006-09-28 | — | — | US | disclosed |
| US-20060182901-A1 | Stretched cellulose ester film, hard coat film, antireflective film, and optical compensation film, and polarizing plate, and display device using them | KONICA MINOLTA OPTO, INC. (JP) | 2006-08-17 | — | — | US | disclosed |
| US-20060115609-A1 | Polarizing plate and display using the same | KONICA MINOLTA OPTO, INC. (JP) | 2006-06-01 | — | — | US | disclosed |
| US-20050271834-A1 | Cellulose ester film and its manufacturing method, optical film, polarizing plate and liquid crystal display | KONICA MINOLTA OPTO, INC. | 2005-12-08 | — | — | US | disclosed |
| US-20050106334-A1 | Polarizing plate and display | KONICA MINOLTA OPTO, INC. | 2005-05-19 | — | — | US | disclosed |
| US-20050062193-A1 | Method of producing dispersion | FUJIFILM CORPORATION (JP) | 2005-03-24 | — | — | US | disclosed |
| US-6630973-B1 | Compensatory sheet, ellipsoidal polarizing plate and liquid crystal display. | FUJI PHOTO FILM CO., LTD. (JP) | 2003-10-07 | — | — | US | disclosed |
| EP-1182470-A1 | PHASE CONTRAST PLATE COMPRISING ONE SHEET OF CELLULOSE ESTER FILM CONTAINING AROMATIC COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 2002-02-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10344032-B2 | Agents for treating neurogenic inflammation and neuropathic hyperalgesia related disorders | TRPV1, P2RX3, P2RX7 | ABCC1 716/4885CA12 4832/4885CA1 3483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.